Trial intelligence / Profile preview

Compound Kushen Injection in Advanced Colorectal Cancer

NCT05894694Phase 4Recruiting

Sponsor
Guang'anmen Hospital
Start
Sep 2023
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of compound kushen injection in colorectal cancer (CRC), sponsored by Guang'anmen Hospital. Started Sep 2023; status: recruiting.

02

Drugs

compound kushen injection
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT05894694.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05894694.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call